Thomas M. Jenkins

2.7k total citations
79 papers, 1.5k citations indexed

About

Thomas M. Jenkins is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas M. Jenkins has authored 79 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 14 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas M. Jenkins's work include Amyotrophic Lateral Sclerosis Research (17 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Multiple Sclerosis Research Studies (11 papers). Thomas M. Jenkins is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (17 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Multiple Sclerosis Research Studies (11 papers). Thomas M. Jenkins collaborates with scholars based in United Kingdom, United States and Australia. Thomas M. Jenkins's co-authors include Ronald J. Wapner, Claudia A. M. Gandini Wheeler‐Kingshott, Ahmed Toosy, Alan J. Thompson, Olga Ciccarelli, Pamela J. Shaw, Christopher McDermott, Iain D. Wilkinson, David H. Miller and James J. P. Alix and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Thomas M. Jenkins

71 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Jenkins United Kingdom 24 444 290 246 224 215 79 1.5k
Mustafa Uzan Türkiye 25 614 1.4× 130 0.4× 290 1.2× 196 0.9× 223 1.0× 105 1.7k
Karen Schreiber Denmark 29 358 0.8× 625 2.2× 84 0.3× 68 0.3× 178 0.8× 85 2.7k
Matthew T. Whitehead United States 20 282 0.6× 142 0.5× 391 1.6× 175 0.8× 243 1.1× 125 1.7k
Edward Pequignot United States 20 157 0.4× 186 0.6× 151 0.6× 333 1.5× 396 1.8× 49 2.5k
Cheng‐Hong Toh Taiwan 27 546 1.2× 135 0.5× 298 1.2× 457 2.0× 162 0.8× 91 2.4k
Laszlo Mechtler United States 25 519 1.2× 370 1.3× 102 0.4× 194 0.9× 123 0.6× 83 1.8k
Keith H. Fulling United States 20 453 1.0× 75 0.3× 184 0.7× 604 2.7× 139 0.6× 22 1.7k
Athanasios K. Petridis Germany 25 768 1.7× 117 0.4× 64 0.3× 88 0.4× 259 1.2× 141 2.1k
G D Perkin United Kingdom 20 1.4k 3.1× 504 1.7× 210 0.9× 86 0.4× 221 1.0× 63 2.5k
Michael J. Noetzel United States 29 514 1.2× 116 0.4× 765 3.1× 783 3.5× 498 2.3× 71 3.0k

Countries citing papers authored by Thomas M. Jenkins

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Jenkins more than expected).

Fields of papers citing papers by Thomas M. Jenkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Jenkins. The network helps show where Thomas M. Jenkins may publish in the future.

Co-authorship network of co-authors of Thomas M. Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Jenkins. A scholar is included among the top collaborators of Thomas M. Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Jenkins. Thomas M. Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeys, Lee, et al.. (2025). The infected total knee replacement: the worst and unfortunately most frequent complication. Orthopaedics and Trauma. 39(1). 42–54.
2.
Sourbron, Steven, et al.. (2025). Quantification of FDG in the spinal cord using PET/MRI. PubMed. 5. 1646662–1646662.
3.
Wamelen, Daniel J. van, Silvia Rota, Monika Hartmann, et al.. (2024). Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study. Clinical Medicine. 24(3). 100209–100209.
4.
Gupta, Khushi, et al.. (2024). Mosquito species identification accuracy of early deployed algorithms in IDX, A vector identification tool. Acta Tropica. 260. 107392–107392. 2 indexed citations
5.
Payne, Thomas, Matthew Appleby, Ellen Buckley, et al.. (2023). A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease. Movement Disorders. 38(8). 1493–1502. 29 indexed citations
6.
Payne, Thomas, Matilde Sassani, Mark Dunning, et al.. (2023). Multimodal assessment of mitochondrial function in Parkinson's disease. Brain. 147(1). 267–280. 10 indexed citations
8.
Jenkins, Thomas M., et al.. (2022). New Neurological Syndromes with COVID-19 Infection: Is Immune System Hyperactivity to Blame? (P3-9.003). Neurology. 98(18_supplement). 1 indexed citations
9.
Payne, Thomas, Matilde Sassani, Ellen Buckley, et al.. (2020). Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study. BMJ Open. 10(8). e038911–e038911. 21 indexed citations
10.
Payne, Thomas, Matthew Appleby, Ellen Buckley, et al.. (2020). Abstracts. Movement Disorders Clinical Practice. 7(S2). 1 indexed citations
11.
Herniman, Julie, et al.. (2015). The analysis of sweat biomarkers in mechanically-loaded tissues using SFC- MS. ePrints Soton (University of Southampton). 2 indexed citations
12.
Jenkins, Thomas M., Hannah Hollinger, & Christopher McDermott. (2014). The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Current Opinion in Neurology. 27(5). 524–531. 35 indexed citations
13.
Olds, David L., Nancy Donelan‐McCall, Ruth O’Brien, et al.. (2013). Improving the Nurse–Family Partnership in Community Practice. PEDIATRICS. 132(Supplement_2). S110–S117. 68 indexed citations
14.
Gorgoraptis, Nikos, Claudia A. M. Gandini Wheeler‐Kingshott, Thomas M. Jenkins, et al.. (2010). Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. Multiple Sclerosis Journal. 16(5). 555–565. 26 indexed citations
15.
Kolappan, Madhan, Thomas M. Jenkins, Claudia A. M. Gandini Wheeler‐Kingshott, et al.. (2009). Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. Journal of Neurology. 256(3). 305–319. 77 indexed citations
16.
Jenkins, Thomas M., Laura Mancini, Olga Ciccarelli, et al.. (2008). Using structural and functional magnetic resonance imaging to explain visual loss at the onset of acute optic neuritis. UCL Discovery (University College London). 1 indexed citations
17.
Jenkins, Thomas M., et al.. (2003). Non‐obstetric surgery during gestation: Risk factors for lower birthweight. Australian and New Zealand Journal of Obstetrics and Gynaecology. 43(1). 27–31. 40 indexed citations
18.
Jenkins, Thomas M. & Ronald J. Wapner. (2000). The challenge of prenatal diagnosis in twin pregnancies. Current Opinion in Obstetrics & Gynecology. 12(2). 87–92. 45 indexed citations
19.
Jenkins, Thomas M., et al.. (2000). Timing of cerclage removal after preterm premature rupture of membranes: Maternal and neonatal outcomes. American Journal of Obstetrics and Gynecology. 183(4). 847–852. 36 indexed citations
20.
Levin, Johannes, et al.. (1977). Endocrine studies on the San ('bushmen') of Botswana.. PubMed. 52(6). 230–2. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026